Freeze-dried Live Attenuated Hepatitis A Vaccine

Product Details

[Specification] After reconstitution in vial form, each 0.5 ml/dose contains
Hepatitis A live attenuated vaccine ≥ 6.5 LgCCID50
[Route of Administration] Subcutaneous injection
[Shelf life] 24 months
[Highlights]
•H2 strain is recognized by WHO
•Only one dose is needed to provide sufficient immune protection against hepatitis A
•Safety and efficacy had been proven in a 15- year clinical observation in China
•70% market share in China
•Marketed in India, Uzbekistan, Pakistan, Philippines, Guatemala and etc；
•Being registered in Thailand, Vietnam, Salvador, Honduras, Nicaragua, Dominican Republic
•Recommended by Indian Academy of Pediatrics (IAP)
•Complete phase I, II, III, IV Clinical Trial conducted in China